(Q34176531)

31 July 2017

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases (English)

1 reference

31 July 2017

1 reference

ChEBI release 2020-05-28

B H Stricker

1

1 reference

31 July 2017

A P Blok

2

1 reference

31 July 2017

F H Claas

3

1 reference

31 July 2017

G E Van Parys

4

1 reference

31 July 2017

V J Desmet

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 1988

1 reference

31 July 2017

1 reference

31 July 2017

8

1 reference

31 July 2017

599-606

1 reference

31 July 2017

3

1 reference

Outpatient Drug-Induced Parenchymal Liver Disease Requiring Hospitalization

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

Hepatic reaction to nitrofurantoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Hepatic injury associated with nitrofurantoin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Trigger factors and HL-A antigens in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

A nitrofurantoin-induced disorder simulating chronic active hepatitis. A case report

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Morphologic changes in adverse drug reactions in infants and children

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Nitrofurantoin: another cause of drug-induced chronic active hepatitis? A report of a patient with HLA-B8 antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Nitrofurantoin-induced chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Nitrofurantoin-induced granulomatous hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Chronic active hepatitis induced by nitrofurantoin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Chronic active hepatitis due to hydroxymethylnitrofurantoin in a male patient

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Diagnostic imaging of focal nodular hyperplasia of the liver developing during nitrofurantoin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.1840080327

1 reference

7 January 2021

Drugs and the ageing liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Nitrofurantoin inhibition of mouse liver mitochondrial respiration involving NAD-linked substrates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080327

7 January 2021

Identifiers

DOI

10.1002/HEP.1840080327

1 reference

31 July 2017

1 reference